Impact of ST-segment resolution following primary angioplasty on outcomes after myocardial infarction in the elderly: An analysis from the controlled abciximab and device investigation to lower late angioplasty complications (CADILLAC) trial
Publication
, Conference
Prasad, A; Stone, G; Aymong, E; Zimetbaum, PJ; McLaughlin, M; Mehran, R; Garcia, E; Tcheng, JE; Cox, DA; Grines, C; Gersh, BJ
Published in: CIRCULATION
October 28, 2003
Duke Scholars
Published In
CIRCULATION
ISSN
0009-7322
Publication Date
October 28, 2003
Volume
108
Issue
17
Start / End Page
537 / 538
Location
ORLANDO, FLORIDA
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Conference Name
76th Annual Scientific Session of the American-Heart-Association
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Prasad, A., Stone, G., Aymong, E., Zimetbaum, P. J., McLaughlin, M., Mehran, R., … Gersh, B. J. (2003). Impact of ST-segment resolution following primary angioplasty on outcomes after myocardial infarction in the elderly: An analysis from the controlled abciximab and device investigation to lower late angioplasty complications (CADILLAC) trial. In CIRCULATION (Vol. 108, pp. 537–538). ORLANDO, FLORIDA: LIPPINCOTT WILLIAMS & WILKINS.
Prasad, A., G. Stone, E. Aymong, P. J. Zimetbaum, M. McLaughlin, R. Mehran, E. Garcia, et al. “Impact of ST-segment resolution following primary angioplasty on outcomes after myocardial infarction in the elderly: An analysis from the controlled abciximab and device investigation to lower late angioplasty complications (CADILLAC) trial.” In CIRCULATION, 108:537–38. LIPPINCOTT WILLIAMS & WILKINS, 2003.
Prasad A, Stone G, Aymong E, Zimetbaum PJ, McLaughlin M, Mehran R, et al. Impact of ST-segment resolution following primary angioplasty on outcomes after myocardial infarction in the elderly: An analysis from the controlled abciximab and device investigation to lower late angioplasty complications (CADILLAC) trial. In: CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2003. p. 537–8.
Prasad, A., et al. “Impact of ST-segment resolution following primary angioplasty on outcomes after myocardial infarction in the elderly: An analysis from the controlled abciximab and device investigation to lower late angioplasty complications (CADILLAC) trial.” CIRCULATION, vol. 108, no. 17, LIPPINCOTT WILLIAMS & WILKINS, 2003, pp. 537–38.
Prasad A, Stone G, Aymong E, Zimetbaum PJ, McLaughlin M, Mehran R, Garcia E, Tcheng JE, Cox DA, Grines C, Gersh BJ. Impact of ST-segment resolution following primary angioplasty on outcomes after myocardial infarction in the elderly: An analysis from the controlled abciximab and device investigation to lower late angioplasty complications (CADILLAC) trial. CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2003. p. 537–538.
Published In
CIRCULATION
ISSN
0009-7322
Publication Date
October 28, 2003
Volume
108
Issue
17
Start / End Page
537 / 538
Location
ORLANDO, FLORIDA
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Conference Name
76th Annual Scientific Session of the American-Heart-Association
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology